In a patient with new‑onset presyncope, supraventricular tachycardia episodes, and metoprolol therapy, what electrocardiogram changes indicate pre‑excitation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ECG Changes Indicating Pre-excitation

Look for a short PR interval (<120 ms), a delta wave (slurred upstroke of the QRS complex), and a widened QRS complex (>120 ms) on the 12-lead ECG. These are the classic electrocardiographic hallmarks of ventricular pre-excitation caused by a manifest accessory pathway 1.

Key ECG Features of Pre-excitation

The pre-excitation pattern reflects early ventricular activation through an accessory pathway that bypasses the normal AV node conduction system 1, 2. The characteristic findings include:

  • Short PR interval: Typically <120 ms, reflecting rapid conduction through the accessory pathway rather than the slower AV node
  • Delta wave: A slurred, slow initial upstroke of the QRS complex representing the fusion of ventricular activation from both the accessory pathway and the normal His-Purkinje system 1
  • Widened QRS complex: Usually >120 ms due to the abnormal ventricular activation sequence 1

The degree of pre-excitation varies depending on the relative contribution of conduction through the normal AV nodal/His-Purkinje system versus the manifest accessory pathway 1.

Important Clinical Caveats

Pre-excitation can be intermittent or subtle, making it easy to miss on a single ECG 1. Even high-risk accessory pathways capable of rapid anterograde conduction may show minimal or inapparent pre-excitation during sinus rhythm 3, 4. In your patient with presyncope and SVT episodes, look for:

  • Variation in PR interval >30 ms across different leads on the same ECG, which can help confirm the presence of an accessory pathway even when the delta wave is not obvious 4
  • Intermittent pre-excitation: Abrupt loss of the delta wave with normalization of the QRS complex suggests a pathway with a relatively long refractory period (generally lower risk) 5

Critical Warning About Metoprolol

In this patient already on metoprolol therapy, be aware that beta-blockers can be dangerous in pre-excitation syndromes. While metoprolol slows AV nodal conduction 6, it does not affect accessory pathway conduction. If the patient develops atrial fibrillation with pre-excitation (pre-excited AF), beta-blockers like metoprolol will not slow conduction through the accessory pathway and may even be harmful by preferentially blocking the AV node, forcing more conduction down the dangerous accessory pathway 2. This can lead to extremely rapid ventricular rates and potentially ventricular fibrillation.

Additional ECG Clues

During tachycardia episodes, the ECG appearance depends on the mechanism:

  • Orthodromic AVRT (most common, 90-95% of cases): Narrow QRS complex with retrograde P waves visible after the QRS, as the accessory pathway conducts only retrogradely during tachycardia 2
  • Antidromic AVRT (5% of cases): Wide QRS complex (maximally pre-excited) as the accessory pathway conducts anterogradely during tachycardia 1

The presence of pre-excitation on ECG combined with documented SVT episodes defines Wolff-Parkinson-White (WPW) syndrome 1, which requires risk stratification and consideration for catheter ablation rather than continued medical management with metoprolol alone.

Related Questions

Is the persistent tachycardia after his emergency department visit due to a change in arrhythmia type, and should he begin metoprolol (beta‑blocker) with guidance on dosing, interaction with losartan (angiotensin II receptor blocker), and criteria for skipping doses based on hypotension or bradycardia?
In a hemodynamically stable 22-year-old patient presenting with palpitations and an electrocardiogram showing an irregular, very rapid wide-complex tachycardia with beat-to-beat variation in QRS morphology, what is the most appropriate acute pharmacological treatment?
In a 62-year-old asymptomatic female with T-wave inversions in leads V1–V4 and sinus bradycardia on electrocardiogram, what is the diagnosis and recommended treatment?
In an 82‑year‑old patient with a heart rate of 50 beats per minute while taking metoprolol 25 mg daily, should the metoprolol be held?
Should a 12‑lead electrocardiogram be obtained in a patient presenting with syncope?
In a patient with new‑onset presyncope and two episodes of spontaneously resolving supraventricular tachycardia, admitted for telemetry and started on metoprolol 25 mg twice daily, what additional investigations should be performed?
Does oral minoxidil increase the risk of pericarditis, particularly in patients with pre‑existing cardiac disease or hypertension?
What is the optimal time of day to take ritlecitinib (once daily)?
In a patient with new‑onset presyncope, documented supraventricular tachycardia episodes, and pre‑excitation on the resting electrocardiogram while taking metoprolol, is there any role for a stress (exercise) electrocardiogram?
What are the recommended treatment medications for Helicobacter pylori infection, including first‑line therapy, alternatives for penicillin allergy, clarithromycin resistance, and rescue therapy?
What specific type of knee immobilizer should I use?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.